Pfizer expects to make $26bn from sale of Covid vaccines

Pfizer Covid vaccine

A medical worker shows a vial with the Pfizer-BioNTech Covid-19 vaccine. 

Photo credit: File | Thomas Kienzle | AFP

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher sales from its Covid-19 vaccine sales.

Welcome!

You're all set to enjoy unlimited Prime content.